Go to article
Posted by CoV Report on October 1, 2021 5:37 pmTags: Categories: US National Stories
An emergency use authorization from the FDA would make molnupiravir the first oral antiviral to combat Covid.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
< The Coronavirus Report home
Everything you need to know to stay updated on the Coronavirus
Leave a Reply